Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine
about
Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation SocietiesEverolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic riskCalcineurin inhibitor withdrawal or tapering for kidney transplant recipients.Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study.Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus.Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimusWound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials
P2860
Q26851935-5830A43C-2CBE-4399-9893-ED4D72E20F3CQ27024676-7EAF170E-2386-4D2D-BEFA-93FD13341C0FQ34843348-6F58668D-0405-46B4-AEBA-110014DFE0F9Q35649082-A1B0985D-576D-44F0-9630-6274BF49B8B6Q38668601-87276063-2D23-40D8-BEA7-310ECCC41A40Q39782344-8BED2E1D-C21C-4D37-AAC3-EE13DE8D0335Q40176051-CC238181-3B81-4FCC-9A02-547F4414C739Q42069171-D3B6E481-FABC-4EC8-BF64-EBACFAE9FEBBQ53570157-1E484E14-72DB-4FB0-AC04-5B11895049BDQ56035477-94CA4996-0E6E-4AE9-B40A-2463ECA3173BQ57793035-27F65A93-764D-4F25-9A8D-03BBE274FAA1
P2860
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine
description
article
@en
im Dezember 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2012
@uk
name
Association of clinical events ...... receiving reduced cyclosporine
@en
Association of clinical events ...... receiving reduced cyclosporine
@nl
type
label
Association of clinical events ...... receiving reduced cyclosporine
@en
Association of clinical events ...... receiving reduced cyclosporine
@nl
prefLabel
Association of clinical events ...... receiving reduced cyclosporine
@en
Association of clinical events ...... receiving reduced cyclosporine
@nl
P2093
P2860
P356
P1476
Association of clinical events ...... receiving reduced cyclosporine
@en
P2093
Catherine Cornu-Artis
Diane Cibrik
Fuad S Shihab
Helio Tedesco-Silva
James Pattison
Laurence Chan
Mario Carmellini
Rowan Walker
Yu Seun Kim
Zailong Wang
P2860
P304
P356
10.1111/CTR.12045
P577
2012-12-12T00:00:00Z